Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 35
Filter
1.
Mar Pollut Bull ; 169: 112557, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34089964

ABSTRACT

Several trace-elements have been identified as indicators of finfish aquaculture organic enrichment. In this study, sediment sampling at finfish farms was completed as part of an Aquaculture Monitoring Program in three distinct Canadian regions. Despite diverse datasets, multivariate analyses show a consistent clustering of known direct (Cu and Zn) and indirect (Cd, Mo and U) tracers of aquaculture activities with sediment organic matter (OM) and/or total dissolved sulfides concentrations. OM content was also a predictor of Cu, Zn, Mo and U concentrations according to decision tree analyses. Distance from cages did not emerge as a strong driver of differences among sampling points; however, a tendency towards negative associations is clear especially for Zn. Enriched stations as determined after geochemical normalization were mostly localized within 150 m of net-pens. Selected trace-elements (in particular Zn) can be useful indicators of aquaculture organic enrichment in different ecosystems and valuable tools for monitoring programs.


Subject(s)
Metals, Heavy , Trace Elements , Water Pollutants, Chemical , Aquaculture , Canada , Ecosystem , Environmental Monitoring , Geologic Sediments , Metals, Heavy/analysis , Trace Elements/analysis , Water Pollutants, Chemical/analysis
2.
Infect Dis Now ; 51(4): 346-350, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33096203

ABSTRACT

INTRODUCTION: The management of prosthetic joint infection requires a complex treatment procedure and can be associated with complications. However, the occurrence of severe adverse events during this intervention has been poorly evaluated. PATIENTS AND METHODS: A 5-year multicentric retrospective study including patients from 3 hospitals in the South-Western France referral center for complex bone and joint infections (Crioac GSO) and treated for hip or knee prosthetic joint infection with 1 or 2-stage implant exchanges. The objective was to describe grade≥3 adverse events, according to the CTCAE classification, occurring within 6 weeks after surgery and to identify their associated factors. RESULTS: One hundred and eighteen patients were identified. We observed 71 severe events in 50 patients (42.3%; 95% confidence interval [CI95%]: 33.8-51.4%). Sixteen severe events were an evolution of the infection. The remaining 55 others (47 grade 3 and 8 grade 4) occurred in 41 patients (34.7%; CI95%: 26.8-43.7%). They were distributed as follows: 27 (49.1%) medical complications, 21 (38.2%) surgical complications and 7 (12.7%) antibiotic-related complications. The main identified risk factor was a two-stage prosthetic exchange with OR=3.6 (CI95% [1.11-11.94], P=0.032). Obesity was limit of significance with OR=3.3 (CI95% [0.9-12.51], P=0.071). Infection with coagulase negative Staphylococcus was a protective factor with OR=0.3 (CI95% [0.12-0.99], P=0.047). CONCLUSION: Severe adverse events are frequent following prosthetic exchange for PJI (34.7%) and are related to the high frequency of comorbidities in this population and to the complex surgical procedures required. The risk factor significantly associated with these events was a two-stage exchange.


Subject(s)
Hip Prosthesis/adverse effects , Joint Diseases/epidemiology , Knee Prosthesis/adverse effects , Prosthesis-Related Infections/epidemiology , Aged , Aged, 80 and over , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/therapeutic use , Arthroplasty, Replacement, Hip/adverse effects , Arthroplasty, Replacement, Knee/adverse effects , Comorbidity , Female , France/epidemiology , Hip Joint/surgery , Humans , Joint Diseases/microbiology , Knee Joint/surgery , Male , Middle Aged , Obesity/epidemiology , Prosthesis-Related Infections/drug therapy , Prosthesis-Related Infections/microbiology , Reoperation/statistics & numerical data , Retrospective Studies , Risk Factors
4.
Expert Opin Drug Saf ; 17(7): 681-695, 2018 07.
Article in English | MEDLINE | ID: mdl-29952667

ABSTRACT

INTRODUCTION: Adverse drug reactions (ADRs) are an important cause of morbidity and mortality worldwide. They are associated with healthcare costs due to hospital admissions or prolonged length of stay, as well as additional interventions. The aim of this study was to conduct a systematic review of observational studies to evaluate the economic impact of preventable ADRs. AREAS COVERED: Published observational research investigating the cost of preventable ADRs in Western countries (limited to the USA and European countries). EXPERT OPINION: Several reviews have been carried out in the field of the ADR epidemiology but fewer reviews have investigated the economic impact of ADRs, and at the time of writing, none has focused on preventable ADRs. The reason why future research should focus on the costs of preventable ADRs is that both the costs and the negative clinical outcomes are preventable, and as such, are a key point of public health policy action. Nevertheless, the present review highlights an important and sobering limitation of published research on the cost of preventable ADRs, of which the major limitation is the heterogeneity in methods and in reporting which limit what can be known through the summarizing work of a systematic review.


Subject(s)
Cost of Illness , Drug-Related Side Effects and Adverse Reactions/economics , Health Care Costs , Drug-Related Side Effects and Adverse Reactions/epidemiology , Hospitalization/economics , Hospitalization/statistics & numerical data , Humans , Length of Stay , Observational Studies as Topic
5.
Nutr Metab Cardiovasc Dis ; 28(6): 533-542, 2018 06.
Article in English | MEDLINE | ID: mdl-29625780

ABSTRACT

Sodium-glucose co-transporter-2 inhibitors (SGLT2-Is) have consistently demonstrated a clinically significant reduction of cardiovascular mortality. However, their safety in clinical practice is still incompletely characterized, and post-marketing monitoring is required considering the expected increase in clinical use. Different analyses of international spontaneous reporting systems, known as disproportionality analyses (DAs), have highlighted the occurrence of ketoacidosis, amputations, acute renal failure and skin toxicity. In this viewpoint, we critically appraise these pharmacovigilance data on SGLT2-Is, with the aim of supporting clinicians in proper interpretation of these studies, and discussing their risk-benefit profile. To this aim, we offer a broad perspective on basic technical aspects subtending DAs of spontaneous reporting databases (describing peculiarities of the Food and Drug Administration Adverse Event Reporting System), their common and evolving uses, key pitfalls in presenting study results (in terms of "risk" or "association") and relevant strategies to account for major confounders. This will also facilitate reviewers and editors in proper evaluation of DAs, and prompt pharmacovigilance experts in converging towards a set of minimum requirements in standardization of design, performance and reporting of DAs. A consensus on quality assessment of DAs will finally establish their transferability to clinical practice. It is anticipated that DAs cannot be used per se as a standalone approach to assess a drug-related risk and cannot replace clinical judgment in the individual patient.


Subject(s)
Adverse Drug Reaction Reporting Systems , Diabetes Mellitus, Type 2/drug therapy , Pharmacovigilance , Sodium-Glucose Transporter 2 Inhibitors/adverse effects , Clinical Decision-Making , Diabetes Mellitus, Type 2/diagnosis , Diabetes Mellitus, Type 2/epidemiology , Humans , Patient Selection , Risk Assessment , Risk Factors , Treatment Outcome
6.
Breast ; 29: 90-5, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27476083

ABSTRACT

PURPOSE: To evaluate toxicity in breast cancer patients treated with anthracycline and taxane based chemotherapy and whole breast hypofractionated radiotherapy, and to identify the risk factors for toxicity. METHODS AND MATERIALS: 537 early breast cancer patients receiving hypofractionated radiotherapy after conservative surgery were enrolled from April 2009 to December 2014, in an Italian cancer institute. The dose was 42.4 Gy in 16 daily fractions, 2.65 Gy per fraction. The boost to the tumor bed was administered only in grade III breast cancer patients and in patients with close or positive margins. Acute and late toxicity were prospectively assessed during and after radiotherapy according to RTOG scale. The impact of patients clinical characteristics, performed treatments and dose inhomogeneities on the occurrence of an higher level of acute skin toxicity and late fibrosis has been evaluated by univariate and multivariate analysis. RESULTS: The mean age was 74 (range 46-91 yrs). 27% of patients received boost. 22% of cases (n = 119) received also chemotherapy. The median follow-up was 32 months. G1 and G2/G3 acute skin toxicity were 61.3% and 20.5% and G1 and G2/G3 late fibrosis 12.6% and 4.3% respectively. Chemotherapy (p = 0.04), diabetes (p = 0.04) and boost administration (p < 0.01) were found to be statistically significant on the occurrence of late fibrosis, but a multivariate analysis did not show any factors connected. The boost administration (p < 0.01), the breast volume (p = 0.05), dose inhomogeneities (p < 0.01) and boost volume (p = 0.04) were found to be statistically significant as concerns the occurrence of acute skin reaction at the univariate analysis, but only the boost administration (p = 0.02), at multivariate analysis. CONCLUSIONS: The results of our study, according to the large randomized trials, confirmed that hypofractionated whole breast irradiation is safe, and only the boost administration seems to be an important predictor for toxicity. Chemotherapy does not impact on acute and late skin toxicity.


Subject(s)
Antineoplastic Agents/adverse effects , Breast Neoplasms/therapy , Chemoradiotherapy, Adjuvant/adverse effects , Radiation Dose Hypofractionation , Radiation Injuries/etiology , Aged , Aged, 80 and over , Anthracyclines/adverse effects , Breast/pathology , Breast/radiation effects , Breast Neoplasms/pathology , Bridged-Ring Compounds/adverse effects , Dose-Response Relationship, Radiation , Female , Fibrosis , Follow-Up Studies , Humans , Middle Aged , Multivariate Analysis , Neoplasm Staging , Prospective Studies , Re-Irradiation/adverse effects , Risk Factors , Skin/radiation effects , Taxoids/adverse effects
7.
Clin Pharmacol Ther ; 99(3): 306-14, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26272741

ABSTRACT

To estimate the risk of sudden cardiac death (SCD) or sudden unexpected death (SUD) related to individual antipsychotics, a meta-analysis of observational studies was performed. Adjusted odds ratio (OR) of SCD/SUD with 95% confidence intervals (CI) were extracted and pooled; heterogeneity was studied using Q statistic and I(2) index, and its potential causes (e.g., hERG blockade potency) explored using meta-regression. Two cohort (740,306 person-years) and four case-control (2,557 cases; 17,670 controls) studies, investigating nine antipsychotics, were included. Compared with nonusers, the risk was increased for quetiapine (OR = 1.72, 95% CI: 1.33-2.23), olanzapine (OR = 2.04, 1.52-2.74), risperidone (OR = 3.04, 2.39-3.86), haloperidol (OR = 2.97, 1.59-5.54), clozapine (OR = 3.67, 1.94-6.94), and thioridazine (OR = 4.58, 2.09-10.05). Heterogeneity was found (Q = 20.0, P = 0.01; I(2) = 60.0%), and the increasing mean hERG blockade potency (P = 0.01) accounted for 43% of this. The SCD/SUD risk differed between individual antipsychotics, and mean hERG blockade potency could be an explanatory factor. This should be considered when initiating antipsychotic treatment.


Subject(s)
Antipsychotic Agents/adverse effects , Death, Sudden, Cardiac/epidemiology , Death, Sudden, Cardiac/etiology , Observational Studies as Topic , ERG1 Potassium Channel , Ether-A-Go-Go Potassium Channels/antagonists & inhibitors , Humans , Inhibitory Concentration 50
8.
Int J Tuberc Lung Dis ; 18(6): 655-62, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24903934

ABSTRACT

SETTING: Tuberculosis (TB) is a major health problem among Tibetans living in exile in India. Although drug-resistant TB is considered common in clinical practice, precise data are lacking. OBJECTIVE: To determine the proportion of drug-resistant cases among new and previously treated Tibetan TB patients. DESIGN: In a drug resistance survey in five Tibetan settlements in India, culture and drug susceptibility testing (DST) for first-line drugs were performed among all consecutive new and previously treated TB cases from April 2010 to September 2011. DST against kanamycin (KM), ethionamide, para-aminosalicylic acid and ofloxacin (OFX) was performed on multidrug-resistant TB (MDR-TB) isolates. RESULTS: Of 307 patients enrolled in the study, 264 (193 new and 71 previously treated) were culture-positive and had DST available. All patients tested for the human immunodeficiency virus (n = 250) were negative. Among new TB cases, 14.5% had MDR-TB and 5.7% were isoniazid (INH) monoresistant. Among previously treated cases, 31.4% had MDR-TB and 12.7% were INH-monoresistant. Of the MDR-TB isolates, 28.6% of new and 26.1% of previously treated cases were OFX-resistant, while 7.1% of new cases and 8.7% of previously treated cases were KM-resistant. Three patients had extensively drug-resistant TB. CONCLUSIONS: MDR-TB is common in new and previously treated Tibetans in India, who also show additional complex resistance patterns. Of particular concern is the high percentage of MDR-TB strains resistant to OFX, KM or both.


Subject(s)
Antitubercular Agents/therapeutic use , Drug Resistance, Multiple, Bacterial , Mycobacterium tuberculosis/drug effects , Refugees , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/ethnology , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/ethnology , Adult , Drug Resistance, Multiple, Bacterial/genetics , Drug Therapy, Combination , Female , Health Care Surveys , Humans , India/epidemiology , Male , Microbial Sensitivity Tests , Middle Aged , Mycobacterium tuberculosis/genetics , Predictive Value of Tests , Prevalence , Risk Factors , Sputum/microbiology , Tibet/ethnology , Time Factors , Treatment Outcome , Tuberculosis, Multidrug-Resistant/diagnosis , Tuberculosis, Multidrug-Resistant/microbiology , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/microbiology , Young Adult
9.
Rev. chil. pediatr ; 84(4): 379-386, jul. 2013. tab
Article in Spanish | LILACS | ID: lil-690540

ABSTRACT

Objetivo: Determinar si la suplementación temprana de hierro disminuye la necesidad, el número y volúmen de glóbulos rojos transfundidos, en relación a la suplementación tardía de hierro en niños con peso de nacimiento menor a 1.301 g. Pacientes y Método: Recién nacidos de muy bajo peso (RNMPN) fueron randomi-zados a recibir suplementación temprana de hierro de 3 mg/kg/día, tan pronto estaban tolerando alimentación enteral de 100 ml/kg/día, o a los 61 días de vida como suplementación tardía. Se midió niveles de hemoglobina al inicio de la suplementación temprana de hierro y a los 2 meses de vida. La transfusión de glóbulos rojos fue restringida de acuerdo a las guías de transfusión y no se administró eritropoyetina. Resultados: No hay diferencias en el número de transfusiones de glóbulos rojos entre los grupos y en relación a las morbilidades asociadas con la prematuridad no habría diferencias significativas. Conclusiones: La suplementación temprana de hierro cuando el niño este tolerando 100 ml/kg/día de leche, no disminuiría la incidencia de las transfusiones de glóbulos rojos en relación al inicio tardío de hierro a los 61 días de vida y probablemente sea segura en los niños menores de 1.301 g.


Objective: Determine whether early iron supplementation would decrease the need, the number and volume of transfused red blood cells in relation to late iron supplementation in children with birth weight less than 1,301 g. Patients and Methods: Very low birth weight (VLBW) infants were randomly assigned to receive early iron supplementation of 3 mg/kg/day as soon as they could tolerate enteral feeding of 100 ml/kg/day, or at 61 days of life as late supplementation. Hemoglobin levels were measured at the beginning of early iron supplementation and at 2 months of age. The red blood cell transfusion was performed according to transfusion guidelines and erythropoietin was not administered. Results: No differences were observed regarding the number of red cell transfusions between the groups. Morbidities associated with prematurity presented no significant differences. Conclusions: Early iron supplementation to a child that is tolerating 100 mL/kg/day of milk, does not decrease the incidence of red blood cell transfusions compared to late start iron at 61 days of life, and it is probably safe in infants with birth weight < 1,301 g.


Subject(s)
Humans , Male , Female , Infant, Newborn , Anemia, Iron-Deficiency/prevention & control , Erythrocyte Transfusion , Infant, Premature, Diseases/prevention & control , Iron/administration & dosage , Infant, Very Low Birth Weight , Anemia, Iron-Deficiency/epidemiology , Dietary Supplements , Enterocolitis, Necrotizing/epidemiology , Enterocolitis, Necrotizing/prevention & control , Ferrous Sulfate , Cerebral Hemorrhage/epidemiology , Cerebral Hemorrhage/prevention & control , Infant, Premature , Prospective Studies , Retinopathy of Prematurity/epidemiology , Retinopathy of Prematurity/prevention & control , Time Factors
10.
J Sports Med Phys Fitness ; 52(6): 616-21, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23187324

ABSTRACT

AIM: The aim of this paper was to report clinical, functional and radiological results of 80 patients surgically treated with a combined mini-open and percutaneous surgical repair as proposed by Kakiuchi. METHODS: All patients were evaluated with a physical examination, evaluation scales, a functional test (Ergo-jump Bosco System), and an ultrasonographic exam along with Power Doppler Ultrasonography (PDU) (S/S). RESULTS: At a mean follow-up of 58 months no cases of rerupture were detected. VISA-A evaluation scale showed an excellent score in 63 patients (78.75%), a good score in 14 patients (17.5%), a fair score in two patients (2.5%), and a poor score in one patient (1.25%). Hannover scale showed an excellent score in 63 patients (78.75%), and a good score in 17 patients (21.25%). Ergo-Jump evaluation showed a 2.07% mean deficit of the affected limb at the Squatting Jump test, a 3.26% mean deficit at the Counter Movement Jump test, and a 0.0062% mean improvement at the Repetitive Jump test. Ultrasonographic exam showed in all cases a satisfactory recovery of the integrity of the operated tendon. The mean AP and LL widths showed a significant increase of 7.13±2.97 mm (+56.1%) and of 4.01±2.36 mm (+43.81%) respectively. According to the modified Öhberg score scale, PDU exam showed a grade +1 in 16 patients (20%) and a grade +2 in seven cases (8.7%). CONCLUSION: The absence of rerupture cases, the satisfactory functional and ultrasonographic results of the patients included in this study cause us to consider this technique as reliable and effective even in young high-demand patients.


Subject(s)
Achilles Tendon/surgery , Ankle Injuries/physiopathology , Ankle Joint/physiopathology , Minimally Invasive Surgical Procedures/methods , Orthopedic Procedures/methods , Tendon Injuries/diagnostic imaging , Ultrasonography, Doppler/methods , Achilles Tendon/diagnostic imaging , Adult , Ankle Injuries/diagnostic imaging , Ankle Joint/surgery , Female , Follow-Up Studies , Humans , Male , Range of Motion, Articular , Retrospective Studies , Rupture/physiopathology , Rupture/surgery , Tendon Injuries/physiopathology , Tendon Injuries/surgery , Treatment Outcome
11.
Clin Pharmacol Ther ; 89(6): 855-66, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21471964

ABSTRACT

As part of the Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project, we reviewed the incidence of cardiovascular (CV) and gastrointestinal (GI) events associated with the use of this category of drugs. We collected data from published meta-analyses (MAs) of clinical trials of nonsteroidal anti-inflammatory drugs (NSAIDs). The Medline, Cochrane, ISI, and SCOPUS databases were systematically searched for MAs of NSAID clinical trials that could potentially contain data on adverse incidents such as myocardial infarction (MI), cerebrovascular events (CeVs), stroke, thromboembolic events (ThEs), heart failure (HF), gastrointestinal bleeding (GIB), and perforation, ulcer, and bleeding (PUB). From 1,733 identified references, 29 MAs were selected for the review. This allowed 109 estimations of incidence rates of CV adverse events and 26 estimations of incidence rates for GI adverse events. No data were found on hemorrhagic stroke or LGIB. Coxibs were studied in more MAs than traditional NSAIDs were (21 MAs for coxibs vs. 7 for traditional NSAIDs; one meta-analysis studied both). Many NSAIDs were not considered in any of the MAs. Our systematic review of MAs included information on the incidence of CV and GI events and identified important knowledge gaps regarding, in particular, the CV safety of traditional NSAIDs.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Cardiovascular Diseases/chemically induced , Gastrointestinal Hemorrhage/chemically induced , Meta-Analysis as Topic , Randomized Controlled Trials as Topic , Cardiovascular Diseases/epidemiology , Gastrointestinal Hemorrhage/epidemiology , Humans , Randomized Controlled Trials as Topic/methods
12.
Clin Exp Rheumatol ; 28(1): 41-8, 2010.
Article in English | MEDLINE | ID: mdl-20346237

ABSTRACT

OBJECTIVES: To characterise the clinical phenotype of Italian patients with adult-onset Still's disease (AOSD). METHODS: Sixty-six subjects who received a definite diagnosis of AOSD were seen and followed-up at our institution from 1991 to 2009. The diagnosis was made by a senior rheumatologist and confirmed by Yamaguchi's criteria for AOSD. Data regarding clinical manifestations, laboratory and radiographic features, and disease course were collected and compared with those reported in other published series of different ethnicity. RESULTS: The most frequent features were: articular pain (100%), acute phase reactants elevation (100%), elevated serum ferritin (97%), high fever (95%), negative RF and ANA (92%), neutrophilia (82%), skin rash (79%), and overt arthritis (79%). Forty-percent of patients showed a chronic articular disease. Five subjects (8%) experienced severe, life-threatening complications, and 1 patient died. As compared to other North American, North European, Middle Eastern, and Far Eastern cohorts, Italian patients showed significant differences in several epidemiologic, clinical and laboratory features. CONCLUSIONS: Our data show that AOSD is rare in the Italian population, and that its clinical presentation appears to be significantly influenced by the ethnicity of the affected patients. Given its broad differential diagnosis, early recognition of this condition is challenging, but it could become crucial in the setting of severe complications. Beyond the protean manifestations of this disease, a clinical picture of seronegative febrile arthritis and skin rash, concurrent with a marked elevation in serum ferritin should always be mindful of AOSD.


Subject(s)
Asian People/statistics & numerical data , Still's Disease, Adult-Onset/complications , Still's Disease, Adult-Onset/ethnology , White People/statistics & numerical data , Acute-Phase Proteins/metabolism , Adolescent , Adult , Aged , Antibodies, Antinuclear/blood , Female , Ferritins/blood , Fever/ethnology , Fever/physiopathology , Humans , Italy/epidemiology , Joints/physiopathology , Male , Middle Aged , Pain/ethnology , Pain/etiology , Pain/physiopathology , Rheumatoid Factor/blood , Still's Disease, Adult-Onset/physiopathology , Young Adult
14.
Eur Ann Allergy Clin Immunol ; 41(2): 50-5, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19585860

ABSTRACT

BACKGROUND: Subjects with drug hypersensitivity are sometimes simultaneously reactive to several drugs. This nosological entity is defined as multiple drug hypersensivity (MDH). Urticaria and angioedema are the commonest clinical manifestations of hypersensitivity drug reactions (HDR). These clinical signs are also pathognomonic of chronic idiopathic urticaria (CIU), whose pathogenetic mechanisms are still largely unknown. The diagnostic algorithm of CIU includes autologous serum skin test (ASST) and autologous plasma skin test (APST), which demonstrated a high positive and negative predictive value, in multiple nonsteroidal anti-inflammatory drugs (NSAIDs) intolerance. OBJECTIVE: to explore the underlying mechanism of MDH and to assess the correlation between such tests and autoimmune diseases (AD). METHODS: Twenty eight subjects with MDH referred to our Allergy/Immunology Unit were enrolled from May 2006 to May 2007. Eight healthy subjects served as controls. In addition to common diagnostic tools used in the diagnostic algorithm of MDH, enrolled subjects also underwent ASST and APST. RESULTS: Patients were predominantly female (23 female vs. 5 male; mean age 52.2 years). In 61% of cases MDH was associated with either CIU or AD. NSAIDs and antibiotics were the major causes of HIDR, both implied in 54% of subjects. The proportions of MDH-subjects with positive ASST and APST were 46.4% and 28.6%, respectively. All patients with MDH+AD+CIU (4/4) presented apositive ASST. CONCLUSIONS: In patients with MDH, ASST proved to be frequently positive, as previously described for multiple NSAIDs intolerance. In ASST-positive subjects, the activity of several drugs appears to add up FceRI-specific autoantibodies in the induction of the release of allergic mediators.


Subject(s)
Autoimmune Diseases/complications , Drug Hypersensitivity/complications , Drug Hypersensitivity/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/immunology , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/immunology , Autoantibodies/immunology , Autoimmune Diseases/epidemiology , Autoimmune Diseases/immunology , Chronic Disease/epidemiology , Drug Hypersensitivity/epidemiology , Drug Hypersensitivity/immunology , Female , Hashimoto Disease/complications , Hashimoto Disease/epidemiology , Humans , Italy , Male , Middle Aged , Receptors, IgE/immunology , Serum/immunology , Skin Tests , Urticaria/complications , Urticaria/epidemiology , Young Adult
15.
Article in English | MEDLINE | ID: mdl-18311621

ABSTRACT

The aim was to assess the influence of mancozeb, zoxamide and copper oxychloride fungicide treatments on Mn, Zn, Cu, Cd and Pb concentrations in Sicilian red wines, grapes, marcs and grape stalks. The experimentation was carried out over two crop years: 2003 and 2004. Trace metals analysis was performed by derivative stripping chronopotentiometry, which allowed detection of concentrations lower than 1 ng g(-1). The data obtained gave evidence that the levels of Mn and Zn in wines from plots treated with zoxamide-mancozeb were about threefold higher than those observed in the control. Wines treated with Cu oxychloride had a significant increase in Cu(II) concentrations with respect to the control; in particular, samples from 2004 showed a 50% increase in Cu levels. Furthermore, as shown in a previous paper, the fungicides treatments studied led to a moderate increase in Pb(II) and Cd(II) levels in treated samples with respect to the control. Wines from 2004 had higher Cu and Pb amounts than wines from 2003; but the concentrations of all the other metals were similar. Statistical analysis of the data by linear discriminant analysis (LDA) and the Kruskal-Wallis test confirmed that both zoxamide-mancozeb treatments and copper oxychloride treatments exerted a significant influence on Mn(II), Zn(II) Cu(II), Pb(II) and Cd(II) concentrations in wines, grapes, marcs and grape stalks samples from both the studied vintages.


Subject(s)
Food Contamination/analysis , Fungicides, Industrial/pharmacology , Metals, Heavy/analysis , Wine , Amides/pharmacology , Cadmium/analysis , Copper/analysis , Copper/pharmacology , Lead/analysis , Linear Models , Maneb/pharmacology , Manganese/analysis , Plant Shoots/chemistry , Sicily , Vitis/chemistry , Wine/analysis , Zinc/analysis , Zineb/pharmacology
16.
Eur Rev Med Pharmacol Sci ; 11(2): 91-100, 2007.
Article in English | MEDLINE | ID: mdl-17552138

ABSTRACT

Bone metastases are the most common tumours affecting the musculoskeletal system. The most frequently affected area of the skeleton is the spine. The vertebral bodies are reached largely via the bloodstream and neoplastic substitution of the bone tissue causes progressive structural destruction leading to loss of stability and compression of the intracanal nerve structures. The treatment of bone metastases in the spine is different and controversial, mostly because of the wide spectrum of clinical and radiographic pattern of the local and systemic disease. Percutaneous vertebroplasty is emerging as one of the most promising new interventional procedures for relieving (or reducing) pain and improve stability. In this article we review indications, contraindications, technique, and complications of percutaneous vertebroplasty in spine metastases.


Subject(s)
Back Pain/etiology , Bone Cements/therapeutic use , Orthopedic Procedures/methods , Polymethyl Methacrylate/therapeutic use , Spinal Neoplasms/surgery , Spine/surgery , Adult , Back Pain/diagnostic imaging , Back Pain/surgery , Bone Cements/adverse effects , Decision Trees , Female , Humans , Male , Middle Aged , Orthopedic Procedures/adverse effects , Polymethyl Methacrylate/adverse effects , Practice Guidelines as Topic , Radiography , Spinal Neoplasms/complications , Spinal Neoplasms/diagnostic imaging , Spinal Neoplasms/secondary , Spine/diagnostic imaging , Treatment Outcome
17.
Rev. chil. pediatr ; 78(3): 253-260, jun. 2007. tab
Article in Spanish | LILACS | ID: lil-473254

ABSTRACT

La asfixia neonatal es una causa importante de mortalidad y secuelas neurológicas. El objetivo de nuestro estudio es identificar los factores de riesgo maternos, perinatales y neonatales asociado a un Puntaje de Apgar (PA) bajo. Pacientes y Método: Se analizan los datos de 57 241 recién nacidos (RN), entre los años 1997 y 2004; los antecedentes fueron ingresados en forma prospectiva a una base de datos computacional. Se realizó un análisis multivariado con un modelo de regresión logística para identificar los factores de riesgo. Resultados: 1 167 presentaron un PA < - 3 al minuto (2,1 por ciento) y 291 presentaron además un puntaje < - 5 a los 5 minutos (0,5 por ciento). Los factores de riesgo de PA bajo estadísticamente significativos fueron: RN de muy bajo peso, malformaciones congénitas mayores, RN pequeño para la edad gestacional, RN pretérmino, embarazo de 42 semanas, expulsivo prolongado, fórceps, desprendimiento placentario y líquido amniótico con meconio. Conclusiones: En este trabajo se identifican los factores de riesgo de PA bajo en nuestra población, los cuales deben ser considerados para una adecuado manejo perinatal.


Subject(s)
Male , Female , Pregnancy , Infant, Newborn , Adult , Humans , Apgar Score , Asphyxia Neonatorum , Infant, Low Birth Weight , Multivariate Analysis , Gestational Age , Infant, Premature , Logistic Models , Maternal Age , Pregnancy Trimester, Third , Prospective Studies , Risk Factors
18.
Eur J Clin Pharmacol ; 63(4): 409-15, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17347806

ABSTRACT

OBJECTIVE: To analyse and discuss the use and the safety profile of individual antiepileptic drugs (AEDs) in Italy. METHODS: The AED safety data referred to the period January 1988-June 2005 and were obtained from the database of the Italian Interregional Group of Pharmacovigilance (GIF). This database collects all spontaneous reports of suspected adverse drug reactions (ADRs) from six Italian regions which are the main contributors to the Italian spontaneous reporting system. Individual AED consumption data (defined daily dose/1,000 inhabitants per day) in the GIF area and in the whole of Italy referred to the period January 2003-June 2005 and were derived from drug sales data (Institute for Medical Statistics Health). RESULTS: Phenobarbital was the most frequently used AED in the GIF area (4.26 DDD/1,000 inhabitants per day) followed by carbamazepine (1.97), valproic acid (1.33) and gabapentin (1.10). AED consumption in the whole of Italy showed a similar pattern. Gabapentin was the most frequently used AED among newer AEDs. In the GIF database 37,906 reports (up to June 2005) were present; 666 of them (1.76%) were associated with at least one AED (Anatomical Therapeutic Chemical code N03A). The AED with the highest number of reports was carbamazepine (208 reports) followed by phenobarbital (98), gabapentin (80), phenytoin (56), valproic acid (55), lamotrigine (51), oxcarbazepine (43) and vigabatrin (35). Use and toxicity profile were evaluated only for AEDs associated with at least 30 reports. Skin reactions were the most frequently reported ADRs, followed by haematological, general condition, hepatic, neurological and gastrointestinal adverse reactions. Phenobarbital, lamotrigine, carbamazepine and phenytoin had the highest percentage of skin reactions (69, 67, 60 and 54%, respectively). Many haematological reactions were reported for each AED; the highest percentage was related to valproic acid (25%). Vigabatrin was associated with the highest percentage of reactions related to hearing, vision and other senses (97%). Phenytoin and valproic acid had the highest percentage of hepatic reactions (30 and 20%), whereas gabapentin of nervous system, psychiatric, gastrointestinal and urinary reactions (26, 21, 21 and 14%, respectively) and phenobarbital of musculoskeletal reactions (13%). CONCLUSIONS: In Italy antiepileptic drug therapy appears to be still dominated by traditional drugs. Our analysis showed a different safety profile related to each AED. Some of the drug-adverse reaction associations discussed are not included in the Italian drug leaflets or have not been reported before in the literature.


Subject(s)
Adverse Drug Reaction Reporting Systems/statistics & numerical data , Anticonvulsants/adverse effects , Adult , Anticonvulsants/therapeutic use , Databases, Factual , Female , Humans , Italy , Male , Middle Aged , Pharmacoepidemiology
19.
Int J Pharm ; 330(1-2): 183-94, 2007 Feb 07.
Article in English | MEDLINE | ID: mdl-17157460

ABSTRACT

Hydrophobic ([tetrakis(2,4-dimetil-3-pentyloxi)-phthalocyaninate]zinc(II)) (ZnPc) and hydrophilic ([tetrakis(N,N,N-trimethylammoniumetoxi)-phthalocyaninate]zinc(II) tetraiodide) (ZnPcMet) phthalocyanines were synthesized and loaded in ultradeformable liposomes (UDL) of soybean phosphatidylcholine and sodium cholate (6:1, w/w, ratio), resulting 100 nm mean size vesicles of negative Zeta potential, with encapsulation efficiencies of 85 and 53%, enthalpy of phase transition of 5.33 and 158 J/mmol for ZnPc and ZnPcMet, respectively, indicating their deep and moderate partition into UD matrices. Matrix elasticity of UDL-phthalocyanines resulted 28-fold greater than that of non-UDL, leaking only 25% of its inner aqueous content after passage through a nanoporous barrier versus 100% leakage for non-UDL. UDL-ZnPc made ZnPc soluble in aqueous buffer while kept the monomeric state, rendering singlet oxygen quantum yield (Phi(Delta)) similar to that obtained in ethanol (0.61), whereas UDL-ZnPcMet had a four-fold higher Phi(Delta) than that of free ZnPcMet (0.21). Free phthalocyanines were non-toxic at 1 and 10 microM, both in dark or upon irradiation at 15 J/cm2 on Vero and J-774 cells (MTT assay). Only liposomal ZnPc at 10 microM was toxic for J-774 cells under both conditions. Additionally, endo-lysosomal confinement of the HPTS dye was kept after irradiation at 15 J/cm2 in the presence of UDL-phtalocyanines. This could lead to improve effects of singlet oxygen against intra-vesicular pathogen targets inside the endo-lysosomal system.


Subject(s)
Indoles/chemistry , Liposomes/chemistry , Radiation-Sensitizing Agents/chemistry , Animals , Calorimetry, Differential Scanning , Cell Survival/drug effects , Chlorocebus aethiops , Indoles/administration & dosage , Indoles/chemical synthesis , Isoindoles , Leishmaniasis, Cutaneous/drug therapy , Liposomes/administration & dosage , Liposomes/chemical synthesis , Macrophages/drug effects , Macrophages/metabolism , Macrophages/radiation effects , Mice , Microscopy, Electron, Transmission , Nanotechnology , Photochemotherapy/methods , Radiation-Sensitizing Agents/administration & dosage , Spectrometry, Fluorescence , Spectrophotometry, Ultraviolet , Vero Cells
20.
Rev. chil. ultrason ; 9(1): 15-20, 2006. ilus, tab
Article in Spanish | LILACS | ID: lil-435455

ABSTRACT

La hernia diafragmática congénita es un defecto del diafragma que permite el desplazamiento de los órganos abdominales hacia la cavidad torácica. A pesar de los avances en el manejo prenatal y postnatal, esta malformación se asocia a una elevada mortalidad. Se presenta una revisión de los casos clínicos con diagnóstico prenatal de hernia diafragmática ingresados al CERPO durante el período 2003-2005. Se analiza en cada caso la edad gestacional al diagnóstico, lado afectado, compromiso hepático, asociación con otras malformaciones y cromosomopatías, resultado perinatal, cirugía y evolución.


Subject(s)
Humans , Adolescent , Adult , Female , Pregnancy , Infant, Newborn , Fetal Diseases , Hernia, Diaphragmatic/congenital , Hernia, Diaphragmatic , Ultrasonography, Prenatal , Clinical Evolution , Echocardiography , Gestational Age , Hernia, Diaphragmatic/surgery , Hernia, Diaphragmatic/complications , Hernia, Diaphragmatic/mortality , Perinatal Care , Prognosis , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...